Organizations today face a dual challenge: accelerating access to data while ensuring that compliance and security never slip through the cracks. But many data teams are stuck in a reactive loop, responding to each and every access request to determine who should be approved versus who should be denied –...
In the pharmaceutical industry, safeguarding sensitive data isn’t just a technical necessity — it’s a regulatory imperative. From clinical trials to manufacturing and commercial operations, pharma organizations manage data that is subject to strict privacy, integrity, and quality requirements, including HIPAA and GxP standards. At the core of meeting these...
Key Takeaways Immuta’s identifiers in domains feature is now generally available to all global customers. It addresses a critical gap in traditional metadata catalogs by making sensitive data discoverable and governable within domain boundaries, which adds critical context to policy enforcement. This capability empowers domain governors to classify and control...
Have you ever felt the frustration of waiting for data access? The demand for data insights is skyrocketing – but often, so is the time it takes to access data. If you’re like more than a third of data professionals, you’re waiting a week or more to gain access after...